期刊文献+

前列腺素E_1抑制血管平滑肌细胞增殖的作用 被引量:5

Effect of prostaglandin E_1 against proliferation of vascular smooth muscle cells
下载PDF
导出
摘要 目的 从细胞周期蛋白和凋亡相关基因探讨前列腺素E1(PGE1)对血管平滑肌细胞 (VSMC)增殖的调控作用。方法 采用培养的新生牛主动脉VSMC ,以胎牛血清及白介素 1(IL 1)分别作为促增殖剂 ,测定不同浓度PGE1对VSMC增殖、细胞内周期蛋白d1mRNA表达、p5 3及Bcl 2基因表达和培养液内NO含量的影响。结果 PGE1浓度依赖性抑制胎牛血清促VSMC增殖作用 ;显著减少细胞周期蛋白d1mRNA含量 ;浓度依赖性诱导IL 1孵育下VSMC产生大量NO ,同时抑制VSMC增殖 ;并促进p5 3基因表达 ,下调bcl 2基因 ,诱导细胞凋亡。结论 PGE1具有抑制VSMC增殖的作用 ,其机制可能与其阻滞VSMC生长有关 ;在炎性因子存在情况下 ,PGE1可诱导VSMC内大量产生NO ,抑制VSMC增殖 ,并加速VSMC凋亡。 AIM To investigate the regulatory action of prostaglandin E 1(PGE 1) on proliferation of vascular smooth muscle cells (VSMC) in respect to cyclin and apoptosis related genes. METHODS Fetal calf serum (FCS) or interleukin (IL 1) were used as proliferation promoter. Cultured VSMC from neonatal bovine aorta were assayed for cyclin d1 mRNA, expression of p53 and bcl 2 genes, and the content of NO after being treated with three doses of PGE 1. RESULTS PGE 1 dose dependently inhibited proliferation of VSMC induced by FCS,decreased the amount of cyclin d1 mRNA; PGE 1 dose dependently induced NO production, increased p53 gene expression while depressing Bcl 2 gene expression of VSMC incubated with IL 1. PGE 1 could induce VSMC apoptosis. CONCLUSION PGE 1 inhibits VSMC proliferation. The mechanism is probably related to the decrease in the cyclin d1 mRNA amount and arrests the cell growth. With the existence of IL 1, PGE 1 induces the production of large amount of NO in VSMC, inhibits VSMC proliferation and accelerates VSMC apoptosis.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2003年第4期257-261,共5页 Chinese Journal of Pharmacology and Toxicology
基金 河南省自然科学基金项目 ( 0 1110 2 0 5 0 2 )~~
关键词 前列腺素EL 平滑 血管 细胞 培养的 基因 BCL-2 基因 p53 细胞周期蛋白类 一氧化氮 prostaglandin E 1 muscle, smooth, vascular cells, cultured genes, bcl 2 genes p53 cyclins nitric oxide
  • 相关文献

参考文献10

  • 1Best PJ, Hasdai D, Sangiorgi G, Schwartz RS, Holmes DR Jr, Simari RD, et al. Apoptosis. Basic concepts and implications in coronary artery disease [ J].Arterioscler Thromb Vasc Biol,1999, 19(1):14-22.
  • 2Dohashi Y, Chigira M, Shoji M, Wakata Y, Kitagawa M,Tamauchi H,et al. Cell cycle control with minimal participation of Cdk2 in a murine fibrosarcoma clone cultured in protein-free medium[J].Biochem Biophys Res Commun,1997, 232(3) :622 - 625.
  • 3Maccarrone M, Fantini C, Ranalli M, Melino G, Agro AF.Activation of nitric oxide synthase is involved in tamoxifeninduced apoptosis of hunmn erythroleukemia K562 cells[ J].FEBS Lett, 1998, 434(3) :421 - 424.
  • 4Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S,et al. Role of nitric oxide in pancreatic tumour growth:in vivo and in vitro studies[J]. Br J Cancer, 1998, 78(7) :841 - 849.
  • 5Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO)donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro[ J ]. J Cardiovasc Pharmacol, 1995, 25(4) :674- 678.
  • 6Iwashina M, Shichiri M, Marumo F, Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells[J]. Circulation, 1998, 98(12) : 1212 - 1218.
  • 7Jin YY, Fang YX.Prostaglandins and leukotrienes cardiovascular pharmacology. In: Chen X, Chen WZ, Zeng GY,eds. Cardiovascular Pharmacology)(心血管药理学)[M].2nd. Beijing: People's Medical Publishing House, 1997.80- 102.
  • 8Komori K, Furuyama T, Shoji T,Kume M, Mori E, Yamaoka T, et al. Inhibitory effect of prostaglandin E1 on intimall thickening caused by poor runoff conditions in the canine autologous vein grafts[ J ]. J Cardiovasc Pharmacol,2001, 38(5) :686 - 692.
  • 9Wang PY, Liu J, Chen ZZ, Luo DC, Wang JY, Sun BY.Nitric oxide inhibitory effect on proliferation of cultured pulmonary artery endothelial cells under normoxia and anoxia[J].Chin J Pharmol Toxicol(中国药理学与毒理学杂志), 1998, 12(4):288-290.
  • 10Messmer UK, Ankarcrona M, Nicotera P, Brune B. p53 Expression in nitric oxide-induced apoptods[ J ]. FEBS Lett, 1994, 355(1):23-26.

同被引文献64

  • 1王卫国.前列腺素E_1治疗不稳定性心绞痛30例临床观察[J].中国基层医药,2004,11(5):525-526. 被引量:3
  • 2张凌.前列腺素E_1治疗38例顽固性心力衰竭疗效观察[J].四川医学,2004,25(8):895-895. 被引量:3
  • 3侯凡,李震一,孟素荣,李爱民,张晓燕,祝善俊.前列腺素E_1对风湿性二尖瓣病变合并肺动脉高压患者血液动力学的影响[J].中国循环杂志,1995,10(10):591-593. 被引量:13
  • 4Hossain M A , Hamamoto l , Kobayashi S , et al . The effect of intrapotal administration of prostaglandin El on liver ischemia and hepatectomy in rats[J]. J Hepatobiliary Pancreat Surg.1998,5(4):437
  • 5TARDIF JC, COTE G, LESPERANCE J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty[J]. N Engl J Med, 1997,337:365-372.
  • 6KANEMITSU S, NISHIKAWA M, ONODA K,et al. Pharmacologic platelet anesthesia by glycoprotein Ⅱb/Ⅲa complex antagonist and argatroban during in vitro extracoreal circulation [ J ]. Thorac Cardiovasc Surg, 2003,126 ( 2 ) :428 -435.
  • 7SCHILNGER M, HAUMER M, SCHLERK G, et al. Restenosis after percutaneous ransluminal angioplasty in the femeoropoliteal segment: the role of inflammation[J]. J Endovasc Ther, 2001,8(5):477-483.
  • 8李建军 李庚山 黄从新.肿瘤坏死因子—α对血管平滑肌细胞核转录因子κB活性的影响[J].中华心血管病杂志,2001,29(4):243-245.
  • 9HO JO Y, IKEDA U, KATSUKI T, et al. Interleukin-6 expression in coronary circulation after coronary angioplasty as factor for restenosis [ J ]. Heart, 2000,84 ( 1 ) :83-87.
  • 10PAPE HC, van GRIENSVEN M, RICE J, et al. Major secondary surgery in blunt truma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical marker[J]. J Thauma, 2001, 50(6): 989-1000.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部